HOME     |     CONTACT


Search  

EastGen News

BOVITEQ ANNOUNCES NEW LICENSEE IN THE NETHERLANDS
Boviteq is pleased to announce that Diamond Genetics in the Netherlands will serve as our In Vitro ...
JDS Article Proves Immunity+® Cows More Resilient To Bird Flu
We're excited to announce that an article by Semex's Dr. Shannon Beard, Mark Carson, Dr. Mi...
SEMEX ANNOUNCES NEW SUBSIDIARY IN HOLLAND
Semex Is Pleased To Announce The Purchase of Semex Holland From Bles Dairies The Semex Board ...
SEMEX ANNOUNCES JON SCHEFERS NAMED US GENERAL MANAGER
Semex Is Pleased To Announce The Appointment of Jon Schefers as the US General Manager, Effectiv...
NEOGEN® AND SEMEX® PARTNER TO DELIVER SEMEX’S IMMUNITY TECHNOLOGY FOR HEALTHIER HERDS
Neogen Corporation and Semex announced today their partnership to deliver Semex’s Immunity Te...
SEMEX ANNOUNCES RYAN LETT SUCCEEDS DAVID MAYO AT SEMEX NEW ZEALAND
Semex is pleased to announce that Ryan Lett will succeed David Mayo as General Manager of Semex N...

View All Articles
SEMEX'S ROLE AND RESPONSIBILITY - NAVIGATING THROUGH COVID-19
Article posted on April 20, 2020, 10:50:29

The world is grappling with an issue of enormous scale and human impact, and our hearts go out to all who have been affected by the outbreak of coronavirus (COVID-19).

 

At Semex, we believe it is our role and responsibility during this time to prioritize the health and well-being of our global staff and clients. We have advised all of our locations and the entire Semex Family to follow the recommendations provided by their local health officials and government leaders working to contain this virus.

 

Right now, we’re working as normally as possible to ensure there is little to no disruption of services to our clients and partners worldwide. We are closely monitoring any changes and will continue to make decisions with vigilance and courage, informed by the latest science-based information and guided by Our Mission and Values.

 

For more information about COVID19 visit World Health Organization.



Print this Article | Email this Article